Flagstar Bank, National Association provides banking products and services in the United States. The company's deposit products include interest-bearing checking and money market, savings, and non-interest-bearing accounts, as well as certificates of deposit. It offers loan products comprising multi-family loans; commercial real estate loans; acquisition, development, and construction loans; commercial and industrial loans; one-to-four family loans; specialty finance loans and leases; warehouse loans; and home equity lines of credit, as well as other consumer loans, including overdraft loans. The company offers non-deposit investment and insurance products; and online and mobile banking services. It primarily serves individuals, small and mid-size businesses, and professional associations. The company was formerly known as Flagstar Financial, Inc. Flagstar Bank, National Association was founded in 1859 and is headquartered in Hicksville, New York.…
3 US Bank Stocks Built For Higher Interest Rates
Flagstar Bank, National Association (NYSE: FLG) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 5,631 employees.
The shares were at 9.960 USD on 20 November 2026, down 6.9% over 52 weeks. Its 52-week range is 9.915 USD to 15.44 USD, and it trades at the bottom of that range.
At a market capitalisation of 3.97B USD, it trades at 66.4 times trailing earnings and 13.8 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a premium of 545% for FLG. It pays a dividend yielding 0.40% (it pays out 27% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
Flagstar Bank, National Association reports return on equity of -2.2%, an operating margin of 16.8% and revenue down 5.6% year over year.
Its debt exceeds its cash by 7.32B USD, a debt-to-equity ratio of 1.50. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 17 analysts cover the stock; their mean price target of 13.18 USD is 32.3% above the current price. The next earnings report is expected on 29 January 2027.